Role of Organic Anions and Phosphatase Enzymes in Phosphorus Acquisition in the Rhizospheres of Legumes and Grasses Grown in a Low Phosphorus Pasture Soil.

Plants (Basel)

Faculty of Agriculture and Life Sciences, P.O. Box 85084, Lincoln University, Lincoln 7647, Christchurch, New Zealand.

Published: September 2020

Rhizosphere processes play a critical role in phosphorus (P) acquisition by plants and microbes, especially under P-limited conditions. Here, we investigated the impacts of nutrient addition and plant species on plant growth, rhizosphere processes, and soil P dynamics. In a glasshouse experiment, blue lupin (), white clover ( L.), perennial ryegrass ( L.), and wheat ( L.) were grown in a low-P pasture soil for 8 weeks with and without the single and combined addition of P (33 mg kg) and nitrogen (200 mg kg). Phosphorus addition increased plant biomass and total P content across plant species, as well as microbial biomass P in white clover and ryegrass. Alkaline phosphatase activity was higher for blue lupin. Legumes showed higher concentrations of organic anions compared to grasses. After P addition, the concentrations of organic anions increased by 11-,10-, 5-, and 2-fold in the rhizospheres of blue lupin, white clover, wheat, and ryegrass, respectively. Despite the differences in their chemical availability (as assessed by P fractionation), moderately labile inorganic P and stable organic P were the most depleted fractions by the four plant species. Inorganic P fractions were depleted similarly between the four plant species, while blue lupin exhibited a strong depletion of stable organic P. Our findings suggest that organic anions were not related to the acquisition of inorganic P for legumes and grasses. At the same time, alkaline phosphatase activity was associated with the mobilization of stable organic P for blue lupin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570192PMC
http://dx.doi.org/10.3390/plants9091185DOI Listing

Publication Analysis

Top Keywords

blue lupin
20
organic anions
16
plant species
16
white clover
12
stable organic
12
phosphorus acquisition
8
legumes grasses
8
pasture soil
8
rhizosphere processes
8
lupin white
8

Similar Publications

Background: Obesity is associated with excessive adipocyte-derived aldosterone secretion, independent of the classical renin-angiotensin-aldosterone cascade, and mineralocorticoid receptor antagonists may be more effective in patients with heart failure (HF) and obesity.

Objectives: This study sought to examine the effects of the nonsteroidal mineralocorticoid receptor antagonist finerenone compared with placebo, according to body mass index (BMI) in FINEARTS-HF (FINerenone trial to investigate Efficacy and sAfety superioR to placebo in paTientS with Heart Failure).

Methods: A total of 6,001 patients with HF with NYHA functional class II, III, and IV, a left ventricular ejection fraction of ≥40%, evidence of structural heart disease, and elevated natriuretic peptide levels were randomized to finerenone or placebo.

View Article and Find Full Text PDF
Article Synopsis
  • Wearable accelerometers provide a way to continuously monitor physical activity in patients with heart failure, which could be useful for assessing treatment effects.
  • In the DETERMINE trials, a subgroup of patients wore accelerometers at different points while also completing questionnaires and walking tests to evaluate their functional status.
  • Results showed that lower activity levels were associated with worse health scores and measures, but overall, the relationships between accelerometer data and health assessments were generally weak, suggesting accelerometers could offer additional insights beyond traditional methods.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the safety and efficacy of finerenone in treating heart failure, focusing on differences between men and women.
  • Conducted as part of the FINEARTS-HF trial, it included over 6000 participants aged 40 and older across multiple countries.
  • Results show that finerenone significantly reduces the risk of combined cardiovascular death and heart failure events in both sexes, with women experiencing slightly better outcomes on average.
View Article and Find Full Text PDF
Article Synopsis
  • Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved outcomes for heart failure patients in the FINEARTS-HF trial but led to elevated serum potassium levels.
  • The study aimed to analyze the frequency of abnormal serum potassium levels (<3.5 mmol/L and >5.5 mmol/L) and the impact of finerenone treatment compared to placebo on patient outcomes.
  • Results showed that participants taking finerenone experienced significantly higher potassium levels over time, with increased risk of levels >5.5 mmol/L and reduced risk of levels <3.5 mmol/L, indicating a notable effect of the drug on potassium regulation.
View Article and Find Full Text PDF

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF.

J Am Coll Cardiol

September 2024

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

Article Synopsis
  • * The FINEARTS-HF trial compared the effectiveness of finerenone, a nonsteroidal mineralocorticoid receptor antagonist, against a placebo, measuring primary outcomes like cardiovascular death and HF worsening events.
  • * Results showed that lower KCCQ Total Symptom Scores (TSS) indicated a higher risk of adverse events, but finerenone significantly reduced event risks across all KCCQ TSS tertiles, suggesting it may improve outcomes for patients with varying levels of symptom severity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!